Analyst Ratings for Gilead Sciences (GILD) [Neutrals]
GILD Rating Summary
GILD Price Target Summary
- Highest: $97.00 (Maxim Group)
- Lowest: $40.00 (Jefferies)
- Average: $64.47
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$64.47 (+14.2%)
Avg. $ Target:
$64.47 (+14.2%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 2/5/2013 | Atlantic Equities | Downgrade | Neutral (Overweight) |
N/A (N/A) |
39.59 | 56.47 | 42.64% | Details |
| 12/13/2012 | Goldman Sachs | New Coverage | Neutral (N/A) |
81.00 (N/A) |
76.23 | 56.47 | -25.92% | Details |
| 11/23/2011 | Argus | Downgrade | Hold (N/A) |
N/A (N/A) |
38.76 | 56.47 | 45.69% | Details |
| 11/22/2011 | Summer Street | Downgrade | Neutral (N/A) |
N/A (N/A) |
36.26 | 56.47 | 55.74% | Details |
| 10/19/2011 | Standpoint Research | Downgrade | Hold (N/A) |
N/A (N/A) |
40.76 | 56.47 | 38.54% | Details |
| 8/26/2010 | First Global | Downgrade | Market Perform (N/A) |
N/A (N/A) |
32.82 | 56.47 | 72.06% | Details |
